An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Contact Your Representative: Support the Medicare Audiology Legislation
The Medicare Audiology Access Improvement Act (H.R. 2757) was reintroduced in the U.S. House—and we need your help to gain critical momentum. This bipartisan bill…
Academy Fights Hearing Aid Specialists Scope Expansion in Nevada
The Academy submitted a letter to the Nevada legislature expressing strong opposition to Assembly Bill 177. The bill proposes expanding the scope of practice for…
Audiologists Advocate for Fair Use of “Doctor” Title in Florida
This week, the American Academy of Audiology, in collaboration with the Florida Academy of Audiology (FLAA), voiced concerns about House Bill (HB) 1341—legislation that would…